Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Analyzing the Growth Rate of the Acute Care Syndromic Testing Market: What’s the Expected CAGR for the Next Decade?

The market size for acute care syndromic testing has seen a swift surge in recent times. The market, which stood at $4.08 billion in 2024, is projected to reach $4.62 billion in 2025, growing at a compound annual growth rate (CAGR) of 13.2%. The observed growth in the previous period is linked to an increase in awareness about antimicrobial resistance and an upsurge in government funding for infectious diseases. Additionally, rising investments in healthcare infrastructure, heightened focus on syndromic testing, the expansion of telemedicine, and an increase in infectious diseases have also contributed to this growth.

In the next few years, the acute care syndromic testing market size is set to experience rapid expansion. Expected to reach a valuation of $7.50 billion in 2029 with a compound annual growth rate (CAGR) of 12.9%, numerous factors are driving this growth. These factors include an increase in infectious diseases, a greater need for quicker diagnostic solutions, healthcare services’ expansion, a rise in the use of multiplex syndromic panels, and the escalating number of elderly people. Key trends in the prediction period encompass the transition to point-of-care testing, the integration of cloud-based platforms, the adoption of multiplex panels, AI-powered tools’ development, and automation in syndromic testing.

Which Major Market Drivers Are Expected to Boost the Acute Care Syndromic Testing Market’s Growth Potential?

The upsurge in infectious diseases is anticipated to boost the acute care syndromic testing market. Infectious diseases, brought about by harmful microorganisms such as bacteria, viruses, fungi, or parasites, can be transmitted between individuals, animals, or even from the environment. The increasing prevalence of these diseases is attributed to factors like population growth, urbanization, international travel, resistance to antimicrobials, and changes in climate, amplifying the necessity for effective countermeasures and treatments. Acute care syndromic testing plays a crucial role in infectious diseases by quickly pinpointing pathogens and co-infections using multiplex molecular diagnostics, facilitating targeted treatment interventions. For example, data from the Health Security Agency, a government agency in the UK, showed that in February 2024, the influenza positivity rate rose to 16.6%, a rise from 14.0% the week prior. Similarly, influenza-like illness (ILI) consultations also escalated, reaching 9.8 per 100,000 people, as opposed to 7.5 per 100,000 in the preceding week. Furthermore, hospitalizations due to influenza surged to 7.63 per 100,000, an increase from the previous week’s 5.12 per 100,000. Consequently, the rising prevalence of infectious diseases is propelling the acute care syndromic testing market.

Request Your Free Acute Care Syndromic Testing Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=21078&type=smp

What are the leading organizations impacting the Acute Care Syndromic Testing market’s growth?

Major companies operating in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Seegene Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.

What Are the Most Prominent Trends Driving Change in the Acute Care Syndromic Testing Market?

Leading firms in the acute care syndromic testing industry are prioritizing technological progress such as the multiplex real-time polymerase chain reaction (PCR) technology to enrich diagnostic precision, expedite pathogen identification, sharpen laboratory processes, lessen response time, and boost patient results through precise and timely treatment measures. Multiplex real-time PCR technology is an innovative molecular diagnostic technique that concurrently detects and measures multiple pathogens or genetic targets in a single PCR reaction, enhancing efficacy and precision in disease diagnosis. As an illustration, in April 2023, QIAGEN N.V., a biotech research firm based in the Netherlands, initiated the QIAstat-Dx syndromic testing solution in Japan, inclusive of a SARS-CoV-2 respiratory panel proficient in identifying over 20 pathogens from a single sample. Using the multiplex real-time PCR technology, it renders swift outcomes with lesser labor compared to individual PCR assays. As of the close of 2022, more than 3,500 systems were globally installed, aiding the diagnosis of respiratory, gastrointestinal, and meningitis-associated conditions. The system is available in over 100 nations, thereby improving syndromic testing access globally.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/acute-care-syndromic-testing-global-market-report

What Are the Core Segments of the Acute Care Syndromic Testing Market, and How Do They Contribute to Growth?

The acute care syndromic testing market covered in this report is segmented –

1) By Disease Type: Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types

2) By Sample Type: Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types

3) By Target: Bacteria, Viruses, Fungi, Parasites

4) By End User: Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users

Subsegments:

1) By Respiratory Diseases: Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases

2) By Gastrointestinal Diseases: Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases

3) By Genitourinary Diseases: Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases

4) By Tropical Diseases: Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases

5) By Other Disease Types: Meningitis, Sepsis, Other Emerging Infectious Diseases

What Regions Are Leading the Charge in the Acute Care Syndromic Testing Market?

North America was the largest region in the acute care syndromic testing market in 2024. The regions covered in the acute care syndromic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Acute Care Syndromic Testing Market Categorized and Defined in the Industry?

Acute care syndromic testing refers to a rapid molecular diagnostic approach that detects multiple pathogens simultaneously from a single patient sample. It is used in emergency and critical care settings to quickly diagnose infectious diseases. This enables faster treatment decisions, improved patient outcomes, and reduced hospital stays.

Browse Through More Similar Reports By The Business Research Company:

Anthrax Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anthrax-vaccine-global-market-report

Dendritic Cell Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dendritic-cell-cancer-vaccine-global-market-report

Cell and Gene Therapy Global Market Report 2025

https://thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: